15 years of revenue, profit, cash flow and balance-sheet history through FY2025,
from SEC filings — with a computed, factual read of the trend.
Updated Overview →
Growth & profitability
Revenue has grown 2.7% per year over the past 5 years.
Net income has grown slower than revenue (-17.8% vs 2.7% per year).
Operating margin has contracted, at 4.3% in the latest year.
Free cash flow has declined 25.9% per year over the past 5 years.
Financial health
Total debt ($1.4B) exceeds cash ($226M); net debt is $1.2B.
Total debt has grown in line with revenue (2.1% vs 2.7% per year).
Operating income covered interest expense 1.3× in the latest year, down from 2.9× 5 years ago.
Total debt is 7.5× EBITDA.
Shareholder returns
Dividends have been paid for 5 consecutive years, consuming 115.4% of earnings and 70.8% of free cash flow.
Revenue & net income
RevenueNet income
Margins (gross / operating / net)
GrossOperatingNet
Free cash flow (CFO − capex)
Free cash flow
Cash vs total debt
CashTotal debt
Cash flow: operating / investing / financing
OperatingInvestingFinancing
Key annual figures
FY
Revenue
Net income
Gross M
Op M
FCF
Total debt
Cash
2025
$2.2B
$25M
41.6%
4.3%
$41M
$1.4B
$226M
2024
$2.3B
$99M
42.4%
8.8%
-$288M
$1.3B
$209M
2023
$2.3B
$115M
41.8%
10.1%
-$266M
$1.4B
$216M
2022
$2.2B
$100M
40.5%
8.4%
$46M
$1.4B
$189M
2021
$2.1B
$118M
45.6%
11.5%
$172M
$1.3B
$479M
2020
$1.9B
$68M
45.2%
9.0%
$185M
$1.3B
$365M
2019
$2.1B
-$372M
45.1%
11.4%
$133M
$1.2B
$342M
2018
$2.2B
$103M
46.2%
0.0%
$197M
$1.3B
$266M
2017
$2.3B
$6M
49.0%
0.0%
$245M
$1.5B
—
2016
—
$179M
—
—
$117M
$1.8B
—
2015
—
-$275M
—
—
$49M
$1.7B
—
2014
—
$356M
—
—
$487M
$2.3B
—
2013
—
$407M
—
—
$659M
$2.2B
—
2012
—
$409M
—
—
—
$2.5B
—
2011
—
$261M
—
—
—
$2.4B
—
Revenue & net income
RevenueNet income
Margins (gross / operating / net)
GrossOperatingNet
Free cash flow (CFO − capex, quarterly)
Free cash flow
Cash vs total debt
CashTotal debt
Cash flow: operating / investing / financing
OperatingInvestingFinancing
Key quarterly figures
Quarter
Revenue
Net income
Gross M
Op M
FCF
Total debt
Cash
Mar '26
$520M
-$11M
41.8%
3.5%
$40M
$1.3B
$300M
Dec '25
$423M
-$66M
38.1%
-4.5%
-$138M
$1.5B
$223M
Sep '25
$537M
-$31M
38.8%
-6.8%
$47M
$1.4B
$226M
Jun '25
$627M
$29M
42.8%
8.6%
$99M
$1.4B
$200M
Mar '25
$517M
$29M
45.9%
9.5%
$28M
$1.4B
$170M
Dec '24
$415M
-$2M
41.6%
2.2%
-$132M
$1.4B
$176M
Sep '24
$518M
$9M
41.1%
3.9%
-$414M
$1.3B
$209M
Jun '24
$648M
$49M
44.3%
12.8%
$89M
$1.3B
$196M
Mar '24
$599M
$36M
43.1%
11.7%
$118M
$1.4B
$196M
Dec '23
$489M
$5M
40.4%
5.3%
-$79M
$1.5B
$214M
Sep '23
$534M
$30M
42.8%
9.8%
$29M
$1.4B
$216M
Jun '23
$650M
$53M
43.1%
13.3%
$154M
$1.3B
$207M
Mar '23
$598M
$19M
40.5%
9.5%
$81M
$1.4B
$155M
Dec '22
$469M
$12M
40.4%
6.8%
-$98M
$1.5B
$184M
Sep '22
$537M
$34M
40.8%
11.0%
$11M
$1.4B
$189M
Jun '22
$624M
$31M
38.6%
8.0%
$100M
$1.4B
$182M
Mar '22
$548M
$24M
42.1%
7.6%
$24M
$1.4B
$188M
Dec '21
$463M
$11M
41.0%
6.9%
-$88M
$1.4B
$240M
Sep '21
$543M
$44M
45.1%
11.6%
$50M
$1.3B
$479M
Jun '21
$574M
$41M
47.1%
12.4%
$163M
$1.3B
$438M
Valuation over time
How the market has priced EPC against its own fundamentals since 2023-03 —
each month-end's share price set against the most recent annual filing, so the multiple moves
as price runs ahead of (or behind) earnings. Split-adjusted.
The price-to-earnings ratio has risen from 19.6× (Mar '23) to 46.2× (Jun '26).
The price-to-sales ratio has fallen from 0.9× (Mar '23) to 0.5× (Jun '26).
The dividend yield has risen from 1.7% (Mar '23) to 2.5% (Jun '26).
Price / earnings (P/E)
P/E
Price / sales (P/S)
P/S
Dividend yield (%)
Dividend yield %
Frequently asked questions
Is EPC growing its revenue and profit?
Over the past 5 years, Edgewell Personal Care Co's revenue has grown 2.7% per year, and net income declined 17.8% per year. These are computed facts, not advice.
How much debt does EPC have?
As of FY2025, Edgewell Personal Care Co reported $1.4B of total debt against $226M of cash; operating income covered interest expense 1.3×.
What is EPC's profit margin?
In FY2025, gross margin was 41.6%, operating margin 4.3%, and net margin 1.1%.
What is EPC's P/E ratio?
As of Jun '26, Edgewell Personal Care Co traded at a price-to-earnings ratio of about 46.2× (market cap ÷ latest annual net income). The valuation charts above show how its P/E, P/S and dividend yield have moved with the share price. These are computed facts, not advice.
Where does this data come from?
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted ·
growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price
against the latest annual filing. Informational only — not investment advice.